The Reality Check

Gartner's research delivers a sobering message: only 11% of leaders report GenAI met their primary business objective. FOMO and vendor pressure often lead to misaligned investments that inflate costs (sometimes 5–10x budget) and dilute benefits.

The Defend/Extend/Upend Framework

Defend: Agent Experience & Productivity

Soft benefits: improve how your team works

Agent assistants
Call summarisation
Knowledge retrieval

Extend: Cost Savings & Revenue

Hard benefits: measurable impact

Virtual customer assistants
Automated quality assurance
Upsell prompts

Upend: Long-term change

Long-term strategic plays

AI-driven contact centres
Minimal human-agent models

Recommendation: Prioritise Defend & Extend for near-term ROI; pursue Upend cautiously as strategic bets.

Critical Success Factors

Rollout Strategy. Target specific agent cohorts.
Change Management. Prevent productivity leakage through training, monitoring, process redesign.
Hidden Costs. Data quality investment, scaling/inference costs, vendor pricing changes, scarce GenAI talent.
Security & Trust. Plan for governance and guardrails from day one.

Strategic Assumptions

By 2026: 75% of GenAI adopters will see productivity gains, mostly as soft benefits.
By 2027: 50% will redesign processes to convert those gains into measurable ROI.

The Bottom Line

"Don't let hype dictate your GenAI investment: let business outcomes drive it."

Back to Blog Get in touch

Strategy

A Frontier Model Just Got Cheaper. Re-Run Your Build-Versus-Buy Maths, Not Your Sign-Off.

Anthropic released Claude Opus 5 at close to half the cost of the previous frontier tier. Cheaper capability changes what is worth automating in claims and legal work, not the standard of review or the named human who signs it. Here is the measured read for regulated operators.

Strategy